Actively Recruiting
Telerehabilitation Dual-Task Training for Parkinson's: A Multidimensional Evaluation
Led by Fenerbahce University · Updated on 2025-06-27
30
Participants Needed
1
Research Sites
65 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In this clinical study, the aim is to assess the effectiveness of telerehabilitation-based dual-task training in improving balance and gait function among individuals diagnosed with Parkinson's Disease. Parkinson's Disease is characterized by motor symptoms such as tremors and slowness of movement, as well as cognitive impairments. While medical treatments help manage symptoms, exercise programs are vital for enhancing physical and cognitive functions. Dual-task training involves combining motor and cognitive activities to enhance gait and balance control, and recent studies have shown its effectiveness in Parkinson's Disease rehabilitation. However, there's limited research on delivering dual-task training through telerehabilitation and determining the optimal content for maximum benefits. This project involves 30 Parkinson's Disease patients who will be randomly assigned to three groups receiving different dual-task exercise programs via telerehabilitation. Each program focuses on combining balance and functional exercises with either cognitive or motor secondary activities. The exercises will be performed three times a week for four weeks under the guidance of a physiotherapist via Zoom. Before and after the intervention, participants will be evaluated for feasibility, gait, balance, cognition, and activity levels. Researchers of this study hypothesize that telerehabilitation-based dual-task training will significantly improve balance and gait function in Parkinson's Disease patients, offering a convenient and effective treatment option to enhance their quality of life.
CONDITIONS
Official Title
Telerehabilitation Dual-Task Training for Parkinson's: A Multidimensional Evaluation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with idiopathic Parkinson's Disease
- Stage 1-3 on the Hoehn-Yahr scale
- Minimum score of 21 on the Montreal Cognitive Assessment Scale
- Stable drug treatment for at least 1 month
- Currently in the "On" period of medication
- Ability to walk independently on level ground (Functional Ambulation Classification 3 or above)
You will not qualify if you...
- Serious hearing or vision problems
- Other neurological, cardiovascular, or orthopedic disorders that prevent walking
- Any other neurological disorder such as dementia or cerebrovascular disease
- Less than 5 years of education
- Vascular lower extremity pathologies
- No internet access via smartphone or computer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Bakırköy Prof. Dr. Mazhar Osman Ruh Sağlığı ve Sinir Hastalıkları Eğitim ve Araştırma Hastanesi
Istanbul, Bakırköy, Turkey (Türkiye)
Actively Recruiting
Research Team
E
Ezgi Gul, MSc, Pt, Research Assistant
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here